DNAprint Genomics (DNAG)

[mingwan0]

Apparently. OK, let's look at the facts such as they are:

Gabriel, Gomez and Bookbinder joined the Life Sciences practice of Semaphore (the US office of which is in Boston) in 2002. We knew that from this (now invalid) link:

http://www.sema4usa.com/Company/events/LifeSciences2002.htm

MBO Announcement
... Richard Gabriel former CEO of Calix Corporation is the point person for the firm
as head of ... I am delighted to join the quality team represented by Semaphore. ...
www.sema4usa.com/Company/events/LifeSciences2002.htm - 43k - Cached - Similar pages

At present there is no mention of personnel in Semaphore's Life Sciences practice on their website and I would imagine that Gabriel and Gomez are no longer involved with Semaphore, but I have no factual evidence of this per se.

Gabriel, Gomez and Bookbinder are also partners in Genbiomics - a Florida registered consulting company. We know very little about Genbiomics and I do not know why it was reinstated in November 2003.

The most revealing item is from the bio about Gabriel on the DNAP website:

http://www.dnaprint.com/2003/corporate/officers.html

"From 2001 until becoming the Chief Executive Officer and President for DNAPrint, he consulted for several start-up companies while working as a partner at Genbiomics, LLC and as head of Life Sciences Practice at Semaphore, Inc."

Now this is still slightly ambiguous in that it is not absolutely clear that he ceased being a partner in Genbiomics and working as Head of the Life Sciences practice at Semaphore on becoming the CEO and President for DNAP, but that would be my reading of the text.

For the avoidance of doubt, it is my belief that Gabriel and Gomez are no longer involved with Semaphore and that Genbiomics is essentially a dormant (though reinstated) entity. Therefore there is no conflict of interest and no undue lack of focus on DNAP as a result of involvement in these entities.

It might be more profitable for you to look at the other things that Gomez is involved in currently.